Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Join Startup Forum Panel at Databricks DATA + AI World Tour in Boston
Tevogen Bio Holdings (Nasdaq: TVGN) announced that its Chief Information Officer and Head of Tevogen.AI, Mittul Mehta, will participate in the Startup Forum panel at the Databricks DATA + AI World Tour on October 8, 2025, in Boston.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Tevogen Bio Holdings (Nasdaq: TVGN) announced that its Chief Information Officer and Head of Tevogen.AI, Mittul Mehta, will participate in the Startup Forum panel at the Databricks DATA + AI World Tour on October 8, 2025, in Boston.
The panel will focus on how early-stage companies are scaling with Databricks, featuring industry leaders including Chris Gervais from Codametrix and Stavros Papadopoulos from TileDB. Mehta will discuss Tevogen.AI's PredicTcell™ platform, developed with Microsoft and Databricks, which aims to accelerate precision immunotherapy development.
Details
News Market Reaction – TVGNW
On Sep 10, the day this news came out, TVGNW closed 6.94% above the previous close. That session’s volume was 14.4x the stock’s average daily volume.
Data tracked by StockTitan Argus for the Sep 10 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WARREN, N.J., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that Mittul Mehta, Chief Information Officer of Tevogen and Head of Tevogen.AI, will participate as a panelist in the Startup Forum at the Databricks DATA + AI World Tour on October 8, 2025.
The Startup Forum will feature insights from venture capital leaders and early-stage innovators on how they are scaling their companies with Databricks. Mehta will join industry peers including Chris Gervais, CTO of Codametrix, and Stavros Papadopoulos, CEO of TileDB, in a discussion moderated by Tony Pezzullo, Principal at SignalFire. Mehta will share perspectives on Tevogen.AI’s application of advanced data and AI technologies, including its PredicTcell™ platform, developed in collaboration with Microsoft and Databricks, to accelerate precision immunotherapy development.
Databricks DATA + AI World Tour will take place at the Sheraton Boston Hotel. For more information please contact, communications@tevogen.com
Contacts
Tevogen Bio Communications
T: 1 877 TEVOGEN, Ext 701
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b86622e6-99bc-4be9-8b77-537a3cb5e357
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.